Health & Science
FDA Advisory Panel Backs Galleri Multi Cancer Blood Test
An FDA advisory panel voted that Galleri's benefits outweigh its risks for adults 50 and older. The vote is advisory and the test is not yet FDA approved.
Health & Science
Research, medicine, biotechnology, AI in science and public health, with close attention to the strength of the evidence and what has not yet been established.
More Health & Science